Mentice AB (SE:MNTC)
:MNTC
Want to see SE:MNTC full AI Analyst Report?
MNTC Stock Chart & Stats
kr13.40
kr0.70(3.37%)
At close: 4:00 PM EST
kr13.40
kr0.70(3.37%)
Day’s Range― - ―
52-Week Rangekr8.50 - kr21.06
Previous CloseN/A
Volume190.00
Average Volume (3M)19.32K
Market Cap
kr365.63M
Enterprise Valuekr358.41M
Total Cash (Recent Filing)kr33.38M
Total Debt (Recent Filing)kr26.15M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
May 07, 2026EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.48
Shares Outstanding28,125,734
10 Day Avg. Volume26,429
30 Day Avg. Volume19,315
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)2.71
Price to Sales (P/S)1.34
P/FCF Ratio-14.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)kr311.00M
Bulls Say, Bears Say
Bulls Say
Revenue MomentumSustained top-line expansion across multiple years indicates growing adoption of Mentice’s simulation offerings and enlarging addressable penetration. Durable revenue momentum supports scale economics, platform stickiness and provides a base to convert content and subscription users into higher lifetime value over time.
Serviceable Balance SheetA historically modest leverage profile and sizeable equity position give the company financial flexibility to fund product development and sales activities despite losses. This buffer reduces insolvency risk, allowing management time to execute on commercialization and margin improvement initiatives.
Recurring And B2B Revenue StreamsA business model mixing hardware/software sales with recurring licenses, content modules, and B2B contracts creates diversified, stickier revenue. Recurring and enterprise relationships tend to be durable, supporting predictable cash inflows and higher customer lifetime value once installed base scale is reached.
Bears Say
Persistent Losses And Margin VolatilityOngoing net losses and volatile margins, including a 2025 gross profit setback, undermine the firm's ability to turn revenue growth into sustainable profitability. Persistent negative margins impair reinvestment, compress returns on equity and make long-term self-funded scaling difficult without operational fixes.
Renewed Cash BurnMaterial negative operating and free cash flow in 2025 signals that core operations no longer generate surplus cash. Renewed cash burn forces dependence on financing, restricts investment flexibility, and raises execution risk for multi-year product development and global commercial expansion plans.
Rising Leverage In 2025An uptick in debt and a higher debt-to-equity ratio reduces financial flexibility just as profitability and cash generation weaken. Increased fixed obligations amplify downside risk in prolonged loss periods and can limit the company's ability to fund R&D or pursue strategic partnerships without dilutive or costly financing.
Mentice AB News
MNTC FAQ
What was Mentice AB’s price range in the past 12 months?
Mentice AB lowest stock price was kr8.50 and its highest was kr21.06 in the past 12 months.
What is Mentice AB’s market cap?
Mentice AB’s market cap is kr365.63M.
When is Mentice AB’s upcoming earnings report date?
Mentice AB’s upcoming earnings report date is May 07, 2026 which is in 6 days.
How were Mentice AB’s earnings last quarter?
Mentice AB released its earnings results on Feb 26, 2026. The company reported kr0.48 earnings per share for the quarter, beating the consensus estimate of kr0.058 by kr0.422.
Is Mentice AB overvalued?
According to Wall Street analysts Mentice AB’s price is currently Overvalued.
Does Mentice AB pay dividends?
Mentice AB does not currently pay dividends.
What is Mentice AB’s EPS estimate?
Mentice AB’s EPS estimate is -0.25.
How many shares outstanding does Mentice AB have?
Mentice AB has 28,125,734 shares outstanding.
What happened to Mentice AB’s price movement after its last earnings report?
Mentice AB reported an EPS of kr0.48 in its last earnings report, beating expectations of kr0.058. Following the earnings report the stock price went up 10.357%.
Which hedge fund is a major shareholder of Mentice AB?
Currently, no hedge funds are holding shares in SE:MNTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mentice AB
Mentice AB (publ) provides endovascular simulation solutions to teaching entities, healthcare systems, and medical device manufacturers. The company operates through Medical Device Industry, Healthcare Systems, and Strategic Alliances segments. It provides software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced and essentials, coronary intermediate, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic artery embolization, radiation safety, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, peripheral angiography, and vascular trauma and cardiac rhythm management, as well as supports interventionalists to transition from transfemoral to transradial access. The company also offers medical simulators for endovascular therapies, and simulator accessories and extensions for endovascular therapies; silicone vasculature for endovascular simulation; cardiac and vascular flow systems; neurovascular flow systems; mentice right heart cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; mentice live learning center, a remote learning with its VIST G endovascular simulation platform. Its products are used to educate, train, and enhance the practitioners in skills. The company operates in Europe, the Middle East, and Africa; Asia Pacific region; and the Americas. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
Bactiguard Holding AB
―
C-Rad AB Class B
―
Acarix AB
―
BrainCool AB
―